Hello all, Below is what Joanne Katz sent me late last

New Post Public Reply Private Reply Replies (0) Message Board
nelito
Hello all,

Below is what Joanne Katz sent me late last night. That is why I posted it. I thought it was the actual presentation.

"It was already on Friday:



A. Beta-Amyloid Diseases
06r. Imaging & Biomarkers: other

Date: Friday 20th - Posters







PARKINSON’S DISEASE BIOMARKER DISCOVERY USING SOMASCAN PROTEOMIC TECHNOLOGY

155


J. Ash, United Kingdom





IDENTIFICATION OF SYNAPTIC PROTEINS DETECTABLE IN THE CEREBROSPINAL FLUID IN THE SEARCH FOR BIOMARKERS OF PRECLINICAL ALZHEIMER'S DISEASE

156


O. Belbin, Spain





DEVELOPMENT OF NEW MASS SPECTROMETRY BASED ASSAYS FOR ANALYSIS OF HUMAN CEREBROSPINAL FLUID

157


G. Brinkmalm, Sweden





RATIONAL DESIGN OF ENVIRONMENT SENSITIVE FLUOROPHORES FOR DETECTION OF AGGREGATED AMYOID PROTEIN BIOMARKERS IN NEUROLOGICAL DISEASES

158


K. Cao, USA





BINDING IN VISUAL WORKING MEMORY: A COGNITIVE BIOMARKER FOR EARLY ALZHEIMER'S DISEASE?

160


M. Heider, Germany





SEARCHING FOR A MOLECULAR SIGNATURE OF ALZHEIMER'S DISEASE IN DOWN SYNDROME PLASMA

161


M.F. Iulita, Canada





PLASMA CHOLINE ACETYLTRANSFERASE IN PATIENTS WITH COGNITIVE IMPAIRMENT AND AD

162


A. Karami, Sweden





THE LYMPRO® ASSAY: A BIOMARKER FOR ALZHEIMER’S DISEASE USING BLOOD SAMPLES FROM CLINICALLY DIAGNOSED ALZHEIMER’S DISEASE AND COGNITIVELY INTACT SUBJECTS

163


L. Kirby, USA





PLASMA AND CSF PROTEINS JOINTLY PREDICT MID-TERM PROGRESSION FROM MCI TO AD

164


B. Lehallier, USA





PREPARATION AND STABILITY TESTING OF A QUALITY CONTROL MATERIAL FOR NEUROCHEMICAL DEMENTIA DIAGNOSTICS ASSAYS

165


P. Lewczuk, Germany





AMYLOID BETA 42/40 CSF CONCENTRATION RATIO WITH TWO NOVEL ASSAYS FOR AN EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE

166


P. Lewczuk, Germany





CYP2D6 GENE AND PLASMA CONCENTRATION OF S-DONEPEZIL AS BIOMARKERS TO PREDICT AND EVALUATE CLINICAL OUTCOME OF DONEPEZIL IN CHINESE ALZHEIMER’S DISEASE PATIENTS

167


J. Lu, China





DECREASED LEVELS OF CGMP IN CSF ARE ASSOCIATED WITH COGNITIVE DECLINE AND AMYLOID PATHOLOGY IN ALZHEIMER’S DISEASE

168


C. Mar, Spain





HIPPOCAMPAL SUBFIELDS REPRODUCIBILITY: A EUROPEAN MULTI-SITE 3T STUDY

169


M. Marizzoni, Italy





A NOVEL IMMUNOASSAY FOR LONGITUDINAL MEASUREMENTS OF AMYLOID-BETA OLIGOMERS IN HUMAN CSF WITH POTENTIAL TO ASSESS THERAPEUTIC RESPONSE TO IMMUNOTHERAPY

170


M. Matijevic, USA





AUTOMATION OF COMMERCIAL AMYLOID-BETA AND TAU ELISAS WILL LOWER INTER-LAB VARIABILITY

171


A. Matzen, Germany





CSF BIOMARKER VARIABILITY IN THE ALZHEIMER´S ASSOCIATION QUALITY CONTROL PROGRAM

172


S. Persson, Sweden





EVALUATION OF RETINAL CHANGES IN MILD COGNITIVE IMPAIRMENT, ALZHEIMER DEMENTIA, NON-ALZHEIMER DEMENTIA AND PD

173


J. Pillai, USA





CHANGES OF PLASMA AMYLOID BETA 40/42 RATIOS IN KOREAN SPORADIC EARLY-ONSET ALZHEIMER'S DISEASE PATIENTS

174


P. Sun Ah, Korea





RED BLOOD CELL FATTY ACIDS ARE SIGNIFICANTLY ALTERED IN SOUTH AUSTRALIAN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE COMPARED TO CONTROLS

175


P. Thomas, Australia





IMPACT OF FREQUENT CSF SAMPLING ON CSF ABETA LEVELS: SYSTEMATIC APPROACH TO ELUCIDATE INFLUENCING FACTORS

176


B. Van Broeck, Belgium





SPEECH DISORDERS IN ALZHEIMER´S DISEASE

177


P. Walecki, Poland





GLYCOSYLATION OF HUMAN PLASMA CLUSTERIN PROVIDES NOVEL BIOMARKERS OF ALZHEIMER’S DISEASE

178


M. Ward, United Kingdom





PLASMA IL-6 AND TRAIL IDENTIFIED AS BIOMARKERS OF ALZHEIMER'S DISEASE

179


Y. Wu, Taiwan









Kind regards,

Joanne Katz
Project Coordinator
kenes-international
Tel: +41 22 9080488 Ext 920
Fax: +41 22 9069140
Email: jkatz@kenes.com
Site: www.kenes.com "

Manolo

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 6

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 2

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 6

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 7

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading

Top 5 Most Recently Viewed Articles

First Industrial Realty Trust Excels in Q2 2025 Performance

Updated Category News Views 170

Strong Financial Results for First Industrial Realty Trust First Industrial Realty Trust, Inc. (NYSE: FR) announced notable financial results for its second quarter of 2025. This leading owner and operator of logistics real estate illustrated a remarkable cash same-store net operating income (NOI) growth of 8.7%, showcasing its strong market position and operational...

Continue Reading
Range Resources Announces New Quarterly Dividend

Updated Category News Views 84

Range Resources Announces New Quarterly Dividend Range Resources Corporation (NYSE: RRC) has shared some exciting news about its dividend distribution. The company's Board of Directors has officially declared a cash dividend of $0.08 per share, which is set to be distributed in the third quarter. This decision highlights Range's dedication to delivering value to its loyal...

Continue Reading
Highlights of Ringkjøbing Landbobank's Recent Buyback Program

Updated Category News Views 157

Completion of the Share Buyback Program The share buyback program initiated by Ringkjøbing Landbobank has successfully completed its target of DKK 500 million. This initiative demonstrated the bank’s commitment to enhancing shareholder value. The buybacks took place between January 28 and May 28. Details of the Transactions During the reporting period, several...

Continue Reading
Monte Rosa Therapeutics Updates on MRT-2359 Study Progress

Updated Category News Views 175

Monte Rosa Therapeutics Announces Progress in MRT-2359 Study Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a pioneering clinical-stage biotechnology company, has shared exciting updates regarding its ongoing Phase 1/2 study of MRT-2359. This innovative treatment targets MYC-driven solid tumors and has shown promising results in patient safety and drug efficacy. Key Study...

Continue Reading
Pentagon Budget Sparks AI Innovations in Defense Sector

Updated Category News Views 103

Defense Sector Transforms with AI Technologies The recent authorization of a significant $900.6 billion Pentagon budget marks the beginning of a dynamic transformation in the defense industry. This substantial financial allocation urges the need for innovation in electronic warfare and advanced sensing technologies as the complexity of modern threats increases. Experts...

Continue Reading